Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iatrogenic perforation of a branch of the descending thoracic aorta during catheter ablation of the left lateral accessory pathway: a case report.

International journal of surgery case reports·2026
Same author

The Value of Anti-Drug Antibody Detection in Discriminating Patients from Healthy Controls and Predicting the Gross Motor Functional State in Patients with Pompe Disease.

Iranian journal of allergy, asthma, and immunology·2026
Same author

Detecting coronary artery disease among the individuals with left-sided dominant coronary circulation.

Caspian journal of internal medicine·2026
Same author

Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials.

Journal of the American Heart Association·2024
Same author

Impact of Drug Elution on Infectious Outcomes after Ductal Stenting in Newborns.

Pediatric cardiology·2024
Same author

Echocardiographic estimation of pulmonary arterial and right atrial pressures in children with congenital heart disease: a comprehensive prospective study and introduction of novel equations.

Journal of cardiovascular imaging·2024

Related Experiment Video

Updated: May 23, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Closure of interatrial defects by immediate-release patch.

Aliakbar Zeinaloo1, Keyhan Sayadpour Zanjani, Bahman Rastkar

  • 1Children's Medical Center, Tehran University of Medical Sciences, 62 Dr Gharib Street, 14194, Tehran, Iran.

Pediatric Cardiology
|March 29, 2012
PubMed
Summary

The novel Immediate-Release Patch offers a wireless, bioabsorbable solution for closing cardiac defects. While generally successful, some residual shunts may occur, requiring further evaluation.

More Related Videos

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

Related Experiment Videos

Last Updated: May 23, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Medical Devices

Background:

  • Cardiac defects necessitate effective closure methods.
  • Transcatheter devices offer less invasive treatment options.
  • Bioabsorbable materials present advantages in medical implants.

Purpose of the Study:

  • To evaluate the safety and efficacy of the Immediate-Release Patch for cardiac defect closure.
  • To assess the performance of this novel bioabsorbable device in clinical practice.

Main Methods:

  • The Immediate-Release Patch was used to attempt closure of 12 atrial septal defects and 1 fenestration.
  • Device implantation success, retrieval, and adverse events were recorded.
  • Follow-up assessments evaluated residual shunts and defect closure status.

Main Results:

  • Successful implantation was achieved in 12 out of 13 attempted procedures.
  • One device dislodged and was percutaneously retrieved; no other major adverse events were reported.
  • At a median 11-month follow-up, two patients had trivial residual shunts, and one had a significant residual defect.

Conclusions:

  • The Immediate-Release Patch demonstrates potential as a wireless, bioabsorbable device for cardiac defect closure, with advantages in specific defect types and sizes.
  • The device's bulkiness and application method require operator adaptation.
  • Further studies are needed to optimize outcomes and minimize residual shunts.